Summary
Microchip Technology Inc. reported a decrease in net sales for the quarter ended June 30, 2025, down 13.4% year-over-year to $1,075.5 million. This decline was primarily attributed to customers managing high inventory levels and delaying orders, exacerbated by adverse economic conditions. The company experienced a net loss of $18.6 million, a significant shift from the net income of $129.3 million in the prior year's comparable quarter, largely due to a substantial dividend payment on Series A Preferred Stock ($27.8 million) and increased operating expenses, particularly in Research and Development (R&D) which rose to 23.8% of net sales. Despite the revenue and profit decline, the company's operational cash flow remained positive at $275.6 million. Management indicated signs of business recovery, with improvements in mixed-signal microcontroller and analog product lines from the previous quarter. Inventory levels saw a reduction, both in dollar amount and days on hand, reflecting inventory correction efforts. The company also provided an update on its financial condition, noting $566.5 million in cash and cash equivalents and prudent management of its debt obligations, with no outstanding borrowings under its revolving credit facility at the end of the quarter.
Financial Highlights
56 data points| Revenue | $1.08B |
| Cost of Revenue | $498.80M |
| Gross Profit | $576.70M |
| R&D Expenses | $255.50M |
| SG&A Expenses | $159.30M |
| Operating Expenses | $544.60M |
| Operating Income | $32.10M |
| Net Income | -$18.60M |
| EPS (Basic) | $-0.09 |
| EPS (Diluted) | $-0.09 |
| Shares Outstanding (Basic) | 539.20M |
| Shares Outstanding (Diluted) | 539.20M |
Key Highlights
- 1Net sales decreased by 13.4% year-over-year to $1,075.5 million for the quarter ended June 30, 2025.
- 2The company reported a net loss of $18.6 million, compared to a net income of $129.3 million in the prior year's quarter.
- 3Net cash provided by operating activities was $275.6 million, demonstrating continued operational cash generation.
- 4Gross profit margin decreased to 53.6% from 59.4% year-over-year, impacted by sales volume, product mix, and unabsorbed capacity charges.
- 5Research and Development (R&D) expenses increased to $255.5 million, representing 23.8% of net sales, up from 19.5% in the prior year.
- 6Cash and cash equivalents decreased to $566.5 million as of June 30, 2025, from $771.7 million as of March 31, 2025.
- 7Management noted signs of business recovery with sequential improvements in certain product lines and geographies.